Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00222105 · OUTCOME

Overall Response Rate

A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life · Source last updated 2017-07-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
Not reported
Time frame
At End of Cycle 1, 28 Days

What was measured

Response rate after completion of first cycle. Measured as the proportion of subjects who have a partial response (PR) or complete response (CR), represented as the overall response rate (ORR). SWOG/IBMTR (Southwest Oncology Group/International Blood and Marrow Transplant Research) criteria utilized to determine multiple myeloma response rates.

Analysis population: Five subjects did not complete first cycle.

Groups in this outcome

Arm 1

Doxil, Thalidomide, Dexamethasone Doxil: Doxil 40 mg/m2 IV day 1 Thalidomide: 50-100 mg day 1-28 Dexamethasone: Dexamethasone 40 mg day 1-4 and 15-18

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm 120

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm 195Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        95
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
description
Response rate after completion of first cycle. Measured as the proportion of subjects who have a partial response (PR) or complete response (CR), represented as the overall response rate (ORR). SWOG/IBMTR (Southwest Oncology Group/International Blood and Marrow Transplant Research) criteria utilized to determine multiple myeloma response rates.
groups
  1. description
    Doxil, Thalidomide, Dexamethasone Doxil: Doxil 40 mg/m2 IV day 1 Thalidomide: 50-100 mg day 1-28 Dexamethasone: Dexamethasone 40 mg day 1-4 and 15-18
    id
    OG000
    title
    Arm 1
param Type
NUMBER
population Description
Five subjects did not complete first cycle.
reporting Status
POSTED
time Frame
At End of Cycle 1, 28 Days
title
Overall Response Rate
type
PRIMARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice